The pharmaceutical filtration market is expected to grow at a CAGR of 8.7% to reach US$ 41.0 Bn in 2032.
Pharmaceutical filtration is the process of separation of solid particles by forcing the mixture through a porous medium and depositing the solid particle on the medium. It is one of the physical techniques for collecting solid particles in various industries along with pharmaceutical industry. Filtration process is utilized in many processes such as solvent & bulk filtration, air filtration, and water filtration. Protein-based drugs are nowadays widely used in inflammatory, infectious and cardiovascular diseases across the world. Increasing incidence of diabetes worldwide is contributing to the rising prevalence of these diseases. Thus, the rising demand of macromolecules such as proteins in the biopharmaceutical industry is likely to boost the growth of the global pharmaceutical filtration market. In addition, stringent regulatory protocols in manufacturing facilities has led to a high demand for pharmaceutical filtration techniques, which further contributes to the growth of the global pharmaceutical filtration market. However, challenges such as involvement of high costs and regulatory protocols for validation and qualification procedures are likely to hamper the market growth of pharmaceutical filtration.
Growing demand for generic medicine along with an increase in production of vaccines worldwide to drive the market growth
The global demand of generic medicine is consistently on the rise. Less cost associated with generic medicines are increasing the purchasing power of the consumer. These factors are driving the growth of the global pharmaceutical filtration market. In addition, increasing demand for vaccines for the global requirement for providing immunization and rising prevalence of Dengue, malaria, and chikungunya across the world are likely to play a significant role in growth of the pharmaceutical filtration market globally
Increasing investment in R&D and sector and technological advancement a key feature of the market
Major pharmaceutical and filtration specialist companies are investing in research and development and are launching their products with new technological advancement. Hence, these factors are further contributing to the growth of the global pharmaceutical filtration market. For instance, Porvair Filtration Group., in January 2020, launched the Teffil range of chemically inert filter cartridge and housings. It is a range of fully optimized high-flow PTFE membrane filters with PFA support hardware, suitable for use within a number of fine chemical applications within the microelectronics industry, including organic stripper, IPA and other solvent recirculation applications.
Microfiltration segment is likely to dominate the global pharmaceutical filtration market
On the basis technique segment, microfiltration techniques segment is likely to hold the largest market share. Factors such as application in separating unwanted particles, efficient removal of microorganisms from the material along with lower cost associated with operation support the dominant position of this segment.
North America is expected to have larger share in the global market
Geographically, the global Pharmaceutical filtration market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Among these regions, North America is expected to hold the largest revenue share through the forecast period. The growing biopharmaceutical industry and the presence of advanced manufacturing facilities are the factors contributing to the growth of the market across the region. Additionally, Asia Pacific is likely to be the fastest growing market due to the presence of a large patient pool and increasing production of vaccines in countries like India and China further contributing to the growth of global pharmaceutical filtration market.
Key Market Players
- Merck KGaA
- GE Healthcare
- Pall Corporation
- Parker Hannifin Corporation
- Sartorius Stedim Biotech S.A.
- Porvair Filtration Group
pharmaceutical filtration market Scope
| Metrics | Details |
| Base Year | 2022 |
| Historic Data | 2021-2022 |
| Forecast Period | 2022-2032 |
| Study Period | 2021-2032 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2032 | US$ 41.0 Bn |
| Growth Rate | CAGR of 8.7 % during 2022-2032 |
| Segment Covered | by Product, Systems, Technique, Application, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US). |
Key Segment Of The pharmaceutical filtration market
By Product, 2022-2032 (USD Million)
• Membrane Filters
• Prefilters and Depth Media Filters
• Single-use Systems
• Cartridge & Capsule Filters
• Filter Holders
• Filtration Accessories
• Other Products
By Scale of Operation, 2022-2032 (USD Million)
• Manufacturing Scale
• Pilot Scale
• R&D Scale Application
• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification
By End User, 2022-2032 (USD Million)
• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other techniques
Regional Overview, 2022-2032 (USD Million)
North America
• US
• Canada
Europe
• Germany
• France
• UK
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
South America
• Mexico
• Brazil
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
North America dominated the market for pharmaceutical filtration market and accounted for the largest revenue share.
To get latest version of pharmaceutical filtration market report can be obtained on demand from the website.
The base year for the report is 2018 in pharmaceutical filtration market.